Literature DB >> 17168212

Metastatic struma ovarii: late presentation, unusual features and multiple radioactive iodine treatments.

J M Zekri1, I H Manifold, J C Wadsley.   

Abstract

Metastatic malignant struma ovarii is rare and there is a lack of agreement on the criteria of diagnosis and the lines of management. Here we describe a patient with struma ovarii that was initially diagnosed as benign and presented 10 years later with distant metastases. At this time, a pathological review of the initial lesion found that it contained invasive well-differentiated follicular carcinoma. The case was associated with a number of unusual features and challenging management issues, such as a delayed diagnosis of recurrence, functioning metastases with treatment consequences, tumour lysis-induced thyrotoxicosis and cerebrospinal fluid rhinorrhea. The diagnosis and management of struma ovarii should be led by an expert multidisciplinary team. Radioactive iodine should be considered in the management of metastatic disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17168212     DOI: 10.1016/j.clon.2006.09.002

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  3 in total

1.  Malignant struma ovarii: a case report.

Authors:  Gülseren Yücesoy; Yigit Cakiroglu; Bahar Muezzinoglu; Birsen Besnili; Izzet Yucesoy
Journal:  J Korean Med Sci       Date:  2010-01-19       Impact factor: 2.153

2.  Thyroid type papillary carcinoma arising in a mature teratoma.

Authors:  Sreekanth S Kumar; P Rema; Anila K R; Bipin T Varghese
Journal:  Indian J Surg Oncol       Date:  2014-07-23

3.  Malignant Clinical Course of "Proliferative" Ovarian Struma: Diagnostic Challenges and Treatment Pitfalls.

Authors:  Aleksandra Asaturova; Alina Magnaeva; Anna Tregubova; Vlada Kometova; Yevgeniy Karamurzin; Sergey Martynov; Yuliya Lipatenkova; Leila Adamyan; Andrea Palicelli
Journal:  Diagnostics (Basel)       Date:  2022-06-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.